Anionic residue in the alpha-subunit of the nicotinic acetylcholine receptor contributing to subunit assembly and ligand binding

被引:35
作者
Sugiyama, N [1 ]
Boyd, AE [1 ]
Taylor, P [1 ]
机构
[1] UNIV CALIF SAN DIEGO, DEPT PHARMACOL, LA JOLLA, CA 92093 USA
关键词
D O I
10.1074/jbc.271.43.26575
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To ascertain the anionic sites on the nicotinic receptor to which acetylcholine and other quaternary ammonium ligands bind, we have examined the role of an aspartyl residue (Asp-152) in the alpha-subunit. Prior photolytic labeling with agonist analogues of the neighboring residues Trp-149 and Try-151 suggests that their side chains reside on the binding face (also termed the (+)- or counterclockwise face) of the alpha-subunit. Asp-152 presents an anionic charge in the vicinity of these aromatic residues. Modification of the aspartate to asparagine (D152N) creates a glycosylation signal (Asn-152-Gly-Ser), and we find, on the basis of altered electrophoretic migration, that glycosylation occurs at this position upon cotransfection of the mutant alpha-subunit with beta-, gamma-, and delta-subunits. Glycosylation results in a reduction in the capacity of the receptor to assemble; this reduction is manifest in the initial step of dimer formation between the alpha gamma- and alpha delta-subunits. The alpha-subunit mutant receptor reaching the assembled pentamer exhibits an altered selectivity for certain ligands, Little reduction in alpha-bungarotoxin binding is observed, whereas affinities for agonists and competitive alkaloid antagonists are reduced substantially. Separation of the contributions of charge removal and glycosylation addition shows that both factors affect agonist affinity, with the charge influence being far more predominant. These findings raise the possibility that a component of the coulombic attraction stabilizing the binding of agonists comes from the aspartyl residue at position 152 in the alpha-subunit.
引用
收藏
页码:26575 / 26581
页数:7
相关论文
共 43 条
[1]   STRUCTURE ACTIVITY AND MOLECULAR MODELING STUDIES OF THE LOPHOTOXIN FAMILY OF IRREVERSIBLE NICOTINIC RECEPTOR ANTAGONISTS [J].
ABRAMSON, SN ;
TRISCHMAN, JA ;
TAPIOLAS, DM ;
HAROLD, EE ;
FENICAL, W ;
TAYLOR, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (06) :1798-1804
[2]  
ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666
[3]  
AMRTIN M, 1996, J BIOL CHEM, V271, P13497
[4]   HOW THE MONGOOSE CAN FIGHT THE SNAKE - THE BINDING-SITE OF THE MONGOOSE ACETYLCHOLINE-RECEPTOR [J].
BARCHAN, D ;
KACHALSKY, S ;
NEUMANN, D ;
VOGEL, Z ;
OVADIA, M ;
KOCHVA, E ;
FUCHS, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7717-7721
[5]   MOLECULAR-BASIS OF THE 2 NONEQUIVALENT LIGAND-BINDING SITES OF THE MUSCLE NICOTINIC ACETYLCHOLINE-RECEPTOR [J].
BLOUNT, P ;
MERLIE, JP .
NEURON, 1989, 3 (03) :349-357
[6]   ACETYLCHOLINESTERASE INHIBITION BY FASCICULIN - CRYSTAL-STRUCTURE OF THE COMPLEX [J].
BOURNE, Y ;
TAYLOR, P ;
MARCHOT, P .
CELL, 1995, 83 (03) :503-512
[7]  
BULLER AL, 1994, MOL PHARMACOL, V46, P858
[8]  
CHIARA D C, 1992, Biophysical Journal, V61, pA106
[9]  
COHEN JB, 1991, J BIOL CHEM, V266, P23354
[10]   IDENTIFICATION OF A NEW COMPONENT OF THE AGONIST BINDING-SITE OF THE NICOTINIC ALPHA-7 HOMOOLIGOMERIC RECEPTOR [J].
CORRINGER, PJ ;
GALZI, JL ;
EISELE, JL ;
BERTRAND, S ;
CHANGEUX, JP ;
BERTRAND, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) :11749-11752